PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

Scientific Lab Show
SLAS
Bio IT
PEGS Boston
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost
Bio Trinity
Anglo Nordic

Advertisement

A&M Stabtest April 26
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
QMB Innovation Centre
Polypure hompage

Enhancing Compliance and Efficiency with a Unified Quality Management System

Why CDMOs should consolidate their QMS landscape and how to do it well

Quality management systems (QMS) that are not continuously challenged and optimised pose compliance
risks, slow down operations and consume valuable resources. For contract development and manufacturing
organisations (CDMOs), the challenge is amplified; systems must meet both regulatory requirements and diverse
customer expectations, often across multiple sites and modalities. This article outlines how a validated, integrated
QMS eliminates fragmented system landscapes, prevents media breaks and delivers measurable gains in speed,
consistency and audit readiness. Using Training, Document and Deviation Management as core examples, practical levers, realistic workload calculations and a platform-based selection approach that scales are highlighted.

When a QMS Turns into a Wave
In growing companies and fast-changing environments, adding “one more form,” “one more step,” or “one more approval” can feel like a pragmatic response to a change request by authorities, customers or internal findings. Over time, that mindset produces layered and locally optimised systems, paper here, spreadsheets there, a point solution somewhere else, each justified at the time, none optimised end-to-end. The result is a QMS wave; complex to navigate, costly to maintain and hard to govern consistently across sites or product lines.

Three questions reveal whether action is necessary:

  • Are paper-based processes still used for core GMP activities
    despite growth, site diversity, or hybrid work?
  • Do we accept media breaks, manual transfers and parallel
    systems interpreted differently by the site?
  • Are special cases embedded in the base workflow, rather
    than documented as controlled exceptions?
The Bridge 28.01
Newcells 3 June 2024, 15:12
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Aseptic Tech